Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-24

Clinical Trial Update: Maximizing Outcomes in Treating Acute Migraine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on acute migraine treatment completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Axsome Therapeutics

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2023-08-24